FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Debt / NOTE 3.375% 5/0
Market price (% of par)
89.18%
Total 13F principal
$193,457,850
Principal change
+$5,052,000
Total reported market value
$178,112,225
Number of holders
33
Value change
+$6,698,370
Number of buys
11
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q4 2020

As of 31 Dec 2020, FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 was held by 33 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $193,457,850 in principal (par value) of the bond. The largest 10 bondholders included LAZARD ASSET MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, Context Capital Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, Birch Grove Capital LP, ADVENT CAPITAL MANAGEMENT /DE/, TENOR CAPITAL MANAGEMENT Co., L.P., WELLS FARGO & COMPANY/MN, and MORGAN STANLEY. This page lists 33 institutional bondholders reporting positions for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.